key: cord-0335944-4cdqstxx
authors: Ma, Wei Feng; Hodonsky, Chani J.; Turner, Adam W.; Wong, Doris; Song, Yipei; Barrientos, Nelson B.; Miller, Clint L.
title: Single-cell RNA-seq analysis of human coronary arteries using an enhanced workflow reveals SMC transitions and candidate drug targets
date: 2020-10-27
journal: bioRxiv
DOI: 10.1101/2020.10.27.357715
sha: 4af1c9c0925650543a16d215e59e266a0ed353a5
doc_id: 335944
cord_uid: 4cdqstxx

Recent advances in single-cell RNA sequencing (scRNA-seq) methods have enabled high-resolution profiling and quantification of cellular expression and transcriptional states. Here we incorporate automated cell labeling, pseudotemporal ordering, ligand-receptor evaluation, and drug-gene interaction analysis into an enhanced and reproducible scRNA-seq analysis workflow. We applied this analysis method to a recently published human coronary artery scRNA dataset and revealed distinct derivations of chondrocyte-like and fibroblast-like cells from smooth muscle cells (SMCs). We highlighted several key ligand-receptor interactions within the atherosclerotic environment through functional expression profiling and revealed several attractive avenues for future pharmacological repurposing. This publicly available workflow will also allow for more systematic and user-friendly analysis of scRNA datasets in other disease systems.

The recent advances in single-cell RNA-sequencing (scRNA-seq) have allowed for ultra-fine 72 gene expression profiling of many diseases at the cellular level, including coronary artery 73 disease (Wirka et al., 2019) . As sequencing costs continue to decline, there has also been a 74 consistent growth in scRNA datasets, analysis tools and applications. Currently, a major 75 challenge with scRNA-seq analysis is the inherent bias introduced during manual cell labeling, 76 in which cells are grouped by cluster and their identities called collectively based on their overall 77 differential gene expression profiles (Aran et al., 2019) . Another draw-back inherent to 78 commonly used scRNA-seq protocols is their destructive nature to the cells, making time-series 79 analyses of the same samples impossible. Instead, these studies must rely on time-points from 80 separate libraries to monitor processes such as clonal expansion and cell differentiation 81 (DiRenzo et al., 2017; Wang et al., 2020) . Bergen et al., 2019; Cao et al., 2019; Manno et al., 2018) . Although the pseudotemporal 91 scale does not reflect the actual time scale, it is a reliable approximation to characterize cell fate 92 and differentiation events, e.g., during organogenesis, disease states, or in response to SARS-

CoV-2 infection (Cao et al., 2019; Chua et al., 2020) .

In this study, we present the application of an enhanced, scalable, and user-friendly scRNA-seq 96 analysis workflow on an existing human coronary artery scRNA-seq dataset. We performed 97 unbiased automatic cell identification at the single-cell level, pseudotemporal analysis, ligand-98 receptor expression profiling, and drug repurposing analysis. Our results demonstrate potential 99 new mechanisms by which SMCs contribute to the atherosclerotic phenotype and signaling 100 within the lesion microenvironment. More importantly, we reveal attractive candidates for future 101 pre-clinical drug interventional studies. This reproducible analysis workflow can also be easily 102 modified and extended to incorporate different tissue data sources and single-cell modalities 103 such as snATAC-seq (Smith and Sheffield, 2020) . 

To evaluate putative cell fate decisions or differentiation events (e.g., SMC phenotypic transition 127 states), we performed pseudotemporal analysis and ultra-fine clustering using 'Monocle3', a 128 method previously applied to normal and diseased states, e.g. embryo organogenesis and 

Comprehensive ligand-receptor analysis shows complex intercellular communications in 153 the human coronary micro-environment and reveals potential drug targets.

To examine the potential cross-talk between different cell types using scRNA-seq data, we 155 compared the ligand and receptor expression profiles of each cell type with experimentally-156 validated interactions using 'scTalk' (Farbehi et al., 2019) . We found that there is an intricate 157 network of signaling pathways connecting different cell types; some cell types, such as OS, 158 8 have stronger and more frequent outgoing signals, whereas other cell types such as 159 Macrophages (Mø) have fewer and weaker incoming and outgoing signals (Fig. 3A) . SMCs,

OSs, and neurons also exhibit a high degree of autocrine signaling profiles (Fig. 3A ).

Specifically, SMCs are shown to have the highest number of outgoing signals and are among 162 those with the least number of incoming signal weights (Fig. 3B ). This suggests that SMCs play cancer treatments such as erlotinib, cetuximab, and gefitinib were shown as potential key 172 mediators of signaling pathways between SMC and FB via DCN (decorin) and EGFR (Fig. 4) . It 173 has been shown that decorin overexpression increases SMC aggregation and SMC-induced 174 calcification at the atherosclerotic plaque (Fischer et al., 2004) . Although the overlap between 175 CAD and cancer has been previously noted, the efficacy and mechanisms of chemotherapy, 

Our findings show that an enhanced, reproducible pipeline for scRNA-seq analysis improve on 182 current standard scRNA-seq bioinformatics protocols. We provide new insights into intricate 9 cellular differentiation and communication pathways while providing actionable and testable 184 targets for future studies (Fig. 5) . In our combined analysis, we found that SMCs give rise to 185 substantial proportions of CH and FB, with the latter associated with worse prognostic markers 186 (Argraves et al., 2009; Carter, 2012; Carter et al., 2018; Pan et al., 2020) . Several FDA-187 approved drugs (e.g., erlotinib, cetuximab, and gefitinib) were shown as potential effectors of 188 SMCs' signaling to FB, and may be used to treat CAD in cancer patients to simplify or augment 189 drug regiments (Camaré et al., 2017) . This is consistent with recent reports showing beneficial 190 effects of the acute promyelocytic drug all-trans-retinoic acid (ATRA) in atherosclerosis mouse 191 models (Pan et al., 2020) .

Although the utilization of this workflow can compensate for many of the shortcomings of current 194 scRNA-seq analyses, we are still unable to perform cell-lineage tracing that reflects actual 195 timescale without additional molecular experiments. However, leveraging mitochondrial DNA 196 variants in snATAC-seq data has enabled lineage tracing analysis in human cells (Lareau et al., 197 2020; Xu et al., 2019) . Likewise, these analyses can ultimately be extended to integrate spatial 198 data and other multi-modal data (Stuart et al., 2019) . In the future as spatial transcriptomics and 199 snATAC-seq data become more widely available, this workflow can be modified to discover 200 signaling pathways or differentiation events at specific tissue locations and time, allowing for 201 more disease-relevant drug-gene interaction analyses (Fig. 5) . Nonetheless, this pipeline can be 202 applied immediately to datasets from other tissues/diseases to generate informative directions 203 for follow-up studies, and is more user-friendly and reproducible compared to standard scRNA 204 analyses.

Data retrieval and pre-processing 208 Human coronary artery scRNA data read count matrix was retrieved from the Gene Expression 209 Omnibus (GEO) using #GSE131780 and loaded into R 4.0, and was preprocessed using 210 standard parameters of the R packages 'Seurat' v.3, and 'Monocle3' as required (Satija et al., package 'scTalk', as previously described in the analysis of glial cells (Farbehi et al., 2019) .

Briefly, this method is based on permutation testing of random networks, where ligand-receptor 233 11 interactions are derived from experimentally derived interactions from the STRING database.

We exported statistically significant differentially expressed genes from 'Seurat' using the 235 'FindMarkers()' function and imported the preprocessed data into 'scTalk'. Then, overall edges 236 of the cellular communication network were calculated using the 'GenerateNetworkPaths()' 237 function, which reflects the overall ligand-receptor interaction strength between each cell type.

Then, the cell types of interest were specified and treeplots were generated using the 

Briefly, ligands and receptors that were deemed significant from 'scTalk' were evaluated using 

Single-cell expression profiling reveals dynamic flux of cardiac 320 stromal, vascular and immune cells in health and injury

Decorin Promotes Aortic Smooth Muscle Cell Calcification and Colocalizes to Calcified 324 Regions in Human Atherosclerotic Lesions

Massively parallel single-cell mitochondrial DNA 329 genotyping and chromatin profiling

RNA velocity of single cells

During Smooth Muscle Cell Phenotypic Switching and Potential Therapeutic Targets for 338

Supervised classification enables rapid annotation of 340 cell atlases

Spatial reconstruction of single-cell 342 gene expression data

Analytical Approaches for ATAC-seq Data Analysis

Comprehensive Integration of Single-Cell Data

Atherosclerosis and Cancer; A 349 Resemblance with Far-reaching Implications

R: A Language and Environment for Statistical Computing

The dynamics and regulators of cell fate decisions are 355 15 revealed by pseudotemporal ordering of single cells

Clonally expanding smooth muscle cells promote 361 atherosclerosis by escaping efferocytosis and activating the complement cascade

Atheroprotective roles of smooth muscle cell 366 phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis

Single-cell 369 lineage tracing by endogenous mutations enriched in transposase accessible mitochondrial 370 DNA